Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 08, 2023

SELL
$76.01 - $86.7 $155,820 - $177,735
-2,050 Reduced 13.6%
13,025 $1 Million
Q1 2023

May 01, 2023

SELL
$77.31 - $88.08 $73,444 - $83,676
-950 Reduced 5.93%
15,075 $1.25 Million
Q3 2022

Nov 10, 2022

BUY
$59.54 - $68.01 $89,310 - $102,015
1,500 Added 10.33%
16,025 $989 Million
Q1 2022

May 04, 2022

BUY
$57.92 - $72.58 $173,760 - $217,740
3,000 Added 26.03%
14,525 $864,000
Q4 2020

Feb 11, 2021

BUY
$56.65 - $64.55 $652,891 - $743,938
11,525 New
11,525 $671,000
Q2 2020

Aug 13, 2020

SELL
$72.34 - $84.0 $635,434 - $737,856
-8,784 Closed
0 $0
Q1 2020

Apr 30, 2020

SELL
$62.63 - $80.22 $1.91 Million - $2.44 Million
-30,449 Reduced 77.61%
8,784 $657,000
Q4 2019

Jan 31, 2020

SELL
$61.62 - $67.78 $84,419 - $92,858
-1,370 Reduced 3.37%
39,233 $2.55 Million
Q3 2019

Nov 08, 2019

SELL
$62.51 - $69.0 $75,012 - $82,800
-1,200 Reduced 2.87%
40,603 $2.57 Million
Q2 2019

Aug 07, 2019

BUY
$61.87 - $69.38 $74,244 - $83,256
1,200 Added 2.96%
41,803 $2.82 Million
Q1 2019

May 01, 2019

BUY
$62.53 - $70.05 $176,897 - $198,171
2,829 Added 7.49%
40,603 $2.64 Million
Q4 2018

Jan 31, 2019

BUY
$60.54 - $79.0 $810,025 - $1.06 Million
13,380 Added 54.85%
37,774 $2.36 Million
Q3 2018

Nov 07, 2018

BUY
$71.28 - $78.92 $70,210 - $77,736
985 Added 4.21%
24,394 $1.88 Million
Q2 2018

Aug 10, 2018

SELL
$64.88 - $75.68 $274,572 - $320,277
-4,232 Reduced 15.31%
23,409 $1.66 Million
Q1 2018

May 09, 2018

BUY
$72.84 - $88.8 $344,314 - $419,757
4,727 Added 20.63%
27,641 $2.08 Million
Q4 2017

Feb 09, 2018

SELL
$71.15 - $83.52 $206,406 - $242,291
-2,901 Reduced 11.24%
22,914 $1.64 Million
Q3 2017

Nov 07, 2017

BUY
$72.11 - $85.47 $440,015 - $521,537
6,102 Added 30.95%
25,815 $2.09 Million
Q2 2017

Aug 09, 2017

BUY
N/A
19,713
19,713 $1.4 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Pictet & Cie (Europe) Sa Portfolio

Follow Pictet & Cie (Europe) Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet & Cie (Europe) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet & Cie (Europe) Sa with notifications on news.